Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination
The DOI matches its Crossref record.
Abstract
BACKGROUND: Little is known about moderators of response to psychotherapy, medication, and combined treatment for chronic forms of major depressive disorder (MDD). We hypothesized that patient preference at baseline would interact with treatment group to differentially affect treatment outcome. METHOD: We report outcomes for 429 patients who participated in a randomized multicenter trial of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy (CBASP), or combination therapy for chronic forms of MDD (DSM-IV criteria) and who indicated their preference for type of treatment at study entry. The primary outcome measures were total scores on the 24-item Hamilton Rating Scale for Depression (HAM-D-24) and categorical definitions of remission or partial response. The patients were recruited between June 1996 and December 1997. RESULTS: There was an interactive effect of preference and treatment group on outcome. The treatment effect varied as a function of preference, and was particularly apparent for patients who initially expressed preference for one of the monotherapies. Patients who preferred medication had a higher remission rate (45.5%) and lower mean HAM-D-24 score (11.6) at study exit if they received medication than if they received psychotherapy (remission rate, 22.2%; mean HAM-D-24 score, 21.0). Patients who preferred psychotherapy had a higher remission rate (50.0%) and lower mean HAM-D-24 score (12.1) if they received psychotherapy than if they received medication (remission rate 7.7%, mean HAM-D-24 score 18.3). Nevertheless, treatment preference was not associated with risk of dropout from the study. CONCLUSIONS: These results suggest that patient preference is a potent moderator of treatment response for patients with chronic forms of MDD; however, relatively low proportions of the patient sample preferred one of the monotherapies, participants were not blinded to treatment assignment, and there was no placebo group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800
Treatment selection in depression.
Cohen, Z. D., & DeRubeis, R. J. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084746 · Cited by 435
“However, studies of the predictive utility of client preference include positive (Kocsis et al. 2009, Mergl et al. 2011, Swift & Callahan 2009, Swift et al. 2011), mixed (Dunlop et al. 2017, Preference Collaborative Review Group 2008, McHugh et al. 2013), and negative (Dunlop et al. 2012b, Leykin…”
BackgroundPersonalized Medicine for Depression: Can We Match Patients With Treatments?
Simon, G. E., & Perlis, R. H. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09111680 · Cited by 365
Freedland, K. E., Mohr, D. C., Davidson, K. W., & Schwartz, J. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318218e1fb · Cited by 369
Client preferences affect treatment satisfaction, completion, and clinical outcome: a meta-analysis
Lindhiem, O., Bennett, C. B., Trentacosta, C. J., & McLear, C. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.06.002 · Cited by 315
Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators
Driessen, E., & Hollon, S. D. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.005 · Cited by 291
Schramm, E., Klein, D. N., Elsaesser, M., Furukawa, T. A., & Domschke, K. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30099-7 · Cited by 255
Self-citationKocsis, J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.144 · Cited by 214
Self-citationGuidi, J., Tomba, E., & Fava, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040476 · Cited by 167
Dunlop, B. W., Binder, E. B., Cubells, J. F., Goodman, M. M., Kelley, M. E., Kinkead, B., Kutner, M., Nemeroff, C. B., Newport, D. J., Owens, M. J., et al. (2012) · Trials · doi:10.1186/1745-6215-13-106 · Cited by 136
“Clinical predictors have included diagnostic subtype [21,22], severity of depression [23], chronicity [15], symptom profiles [24], patient treatment preference [25], early life stress [19], personality profiles [26], previous treatment [27], psychomotor speed [28], and comorbid diagnoses [29].”
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Mergl, R., Henkel, V., Allgaier, A.-K., Kramer, D., Hautzinger, M., Kohnen, R., Coyne, J., & Hegerl, U. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000318772 · Cited by 126
“Most of the 174 investigated patients with available data stated a preference for one treatment over the other. Nevertheless, there were no significant differences in treatment outcome between patients who got their treatment of choice versus those who did not. Therefore, the authors concluded that treatment preferenc…”
BackgroundZhang, Z., Zhang, L., Zhang, G., Jin, J., & Zheng, Z. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1610-5 · Cited by 99
Delevry, D., & Le, Q. A. (2019) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-019-00379-6 · Cited by 88
Williams, R., Farquharson, L., Palmer, L., Bassett, P., Clarke, J., Clark, D. M., & Crawford, M. J. (2016) · BMC Psychiatry · doi:10.1186/s12888-015-0702-8 · Cited by 76
“Some studies indicate that receiving preferred treatment conveys an additional benefit in terms of clinical measures and treatment retention [13, 14] as well as cost-effectiveness [15], while others find no effect [16, 17].”
BackgroundShould treatment for depression be based more on patient preference?
Winter, S., & Barber, J. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s52746 · Cited by 73
“It was found that preference match for psychotherapy or medication was associated with a greater remission rate.(31) In the other study, all patients received antidepressant medication in the first phase of the study.”
Koszycki, D., Bisserbe, J.-C., Blier, P., Bradwejn, J., & Markowitz, J. (2012) · Archives of Women's Mental Health · doi:10.1007/s00737-012-0277-z · Cited by 49
“Fourth, we regret not having assessed patient treatment preference and treatment credibility, as theymay be important moderators of treatment outcome (Kocsis et al. 2009).”
BackgroundSelf-citationHanson, K., Webb, T. L., Sheeran, P., & Turpin, G. (2016) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465815000041 · Cited by 41
Huijbers, M. J., Spinhoven, P., Spijker, J., Ruhé, H. G., van Schaik, D. J. F., van Oppen, P., Nolen, W. A., Ormel, J., Kuyken, W., van der Wilt, G. J., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.023 · Cited by 43
The Neglected Role of Psychotherapy for Treatment-Resistant Depression
Markowitz, J. C., Wright, J. H., Peeters, F., Thase, M. E., Kocsis, J. H., & Sudak, D. M. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21050535 · Cited by 41
Self-citationSchumm, J. A., Walter, K. H., Bartone, A. S., & Chard, K. M. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.04.006 · Cited by 41
Treatment Selection in Depression: The Role of Clinical Judgment
Tomba, E., & Fava, G. A. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.003 · Cited by 35
Wang, S.-M., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2015) · Psychiatry Investigation · doi:10.4306/pi.2015.12.2.155 · Cited by 36
Metadata
- Authors
- Kocsis, J. H., Leon, A. C., Markowitz, J. C., Manber, R., Arnow, B., Klein, D. N., & Thase, M. E.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2009-01-13
- Volume
- 70
- Issue
- 3
- Pages
- 354-361
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2154528046
- Cited by
- 173
- References
- 0
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.